Recommended Alerts

Sign Up For Alerts

SEC Charges Life Sciences Company with Regulation FD Violations

On August 20, 2019, the SEC settled charges against TherapeuticsMD, a Florida-based life sciences company, for violating Regulation FD by selectively communicating to sell-side analysts information about meetings with FDA.

Read More

Second Circuit Holds Patent No-Challenge Clause Unenforceable

Practices: Life Sciences, Intellectual Property Transactions

Printer-Friendly Version

Cookie Settings